Movement Disorders (diet therapy) < Movement Disorders (drug therapy) < Movement Disorders (epidemiology)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 62.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
002127 (2008)	Roberto Di Fabio ; Carlo Casali ; Francesco Pierelli	Quetiapine: an alternative treatment in painless legs and moving toes.
002189 (2008)	Wendy Phillips [Royaume-Uni] ; Kathleen M. Shannon ; Roger A. Barker	The current clinical management of Huntington's disease.
002279 (2008)	Maria V. Alvarez [États-Unis] ; Erika E. Driver-Dunckley ; John N. Caviness ; Charles H. Adler ; Virgilio Gerald H. Evidente	Case series of painful legs and moving toes: clinical and electrophysiologic observations.
002323 (2008)	Jordan S. Dubow ; Michael Rezak ; Andrew A. Berman	Reversible corneal edema associated with amantadine use: an unrecognized problem.
002361 (2008)	Jennifer G. Goldman [États-Unis] ; Christopher G. Goetz ; Melanie Brandabur ; Michelle Sanfilippo ; Glenn T. Stebbins	Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
002667 (2010)	Andreas A. Argyriou ; Spyridon Papapetropoulos	Botulinum toxin type a for painful limbs moving extremities.
002760 (2009)	Susanne A. Schneider [Royaume-Uni] ; Coro Paisan-Ruiz ; Ines Garcia-Gorostiaga ; Niall P. Quinn ; Yvonne G. Weber ; Holger Lerche ; John Hardy ; Kailash P. Bhatia	GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias.
002838 (2009)	Neema Kasravi [Canada] ; Mandar S. Jog	Botulinum toxin in the treatment of lingual movement disorders.
002B14 (2010)	Victor Peralta [Espagne] ; Maria S. Campos ; Elena García De Jal N ; Manuel J. Cuesta	Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders.
002E08 (2010)	Markus Naumann [Allemagne] ; Alastair Carruthers ; Jean Carruthers ; Sheena K. Aurora ; Ross Zafonte ; Susan Abu-Shakra ; Terry Boodhoo ; Mary Ann Miller-Messana ; George Demos ; Lynn James ; Frederick Beddingfield ; Amanda Vandenburgh ; Mary Ann Chapman ; Mitchell F. Brin	Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications.
002F92 (1990)	G. Iliceto [Royaume-Uni] ; P D Thompson ; B L Day ; J C Rothwell ; A J Lees ; C D Marsden	Diaphragmatic flutter, the moving umbilicus syndrome, and "belly dancer's" dyskinesia.
003064 (1990)	C G Goety ; C M Tanner ; J A Cohen ; J A Thelen ; V S Carroll ; H L Klawans ; R G Fariello	L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
003098 (2011)	Aida Ormazabal ; Mercedes Serrano ; Angels Garcia-Cazorla ; Jaume Campistol ; Rafael Artuch ; Pedro Castro De Castro ; Estíbaliz Barredo-Valderrama ; Judith Armstrong ; Claudio Toma ; Bru Cormand	Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype.
003185 (2011)	Anastasios Bonakis ; Ilia Kritikou ; Emmanouil Vagiakis ; Serafim Nanas ; Sokratis G. Papageorgiou	A familial case of sleep rhythmic movement disorder persistent into adulthood; approach to pathophysiology.
003429 (2012)	Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl Kieburtz	Pharmacologic approaches to the treatment of Huntington's disease.
003804 (1990)	J. Artieda [Espagne] ; M R Luquin ; J. Vaamonde ; J. Laguna ; J A Obeso	Generalized reflex myoclonus in a patient with alcohol-sensitive spontaneous myoclonus and an abnormal gait.
003806 (1990)	A S Walters ; W. Hening ; S. Chokroverty	Opioid therapy in the movement disorders.
003807 (1990)	H. Imai ; H. Narabayashi	A case of pure akinesia due to Lewy body parkinson's disease with pathology.
003912 (2012)	Stewart A. Factor	Propranolol therapy for tardive dyskinesia revisited.
003922 (2013)	Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. Fox	Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
003958 (2013)	Raja Mehanna [États-Unis] ; Christine Hunter ; Anthony Davidson ; Joohi Jimenez-Shahed ; Joseph Jankovic [États-Unis]	Analysis of CYP2D6 genotype and response to tetrabenazine.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Movement Disorders (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Movement Disorders (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Movement Disorders (drug therapy)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024